Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 35.96 CNY | -0.06% |
|
-1.29% | -21.17% |
| Market Cap | 23.95B 3.57B 3.07B 2.89B 2.64B 4.94B 337B 4.95B 34.13B 13.24B 173B 13.4B 13.1B 557B | P/E 2026 * |
26.8x | P/E 2027 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 23.95B 3.57B 3.07B 2.89B 2.64B 4.94B 337B 4.95B 34.13B 13.24B 173B 13.4B 13.1B 557B | EV / Sales 2026 * |
4.86x | EV / Sales 2027 * | 4.48x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.06% | ||
| 1 week | -1.29% | ||
| Current month | -0.22% | ||
| 1 month | -3.59% | ||
| 3 months | -8.27% | ||
| 6 months | -12.29% | ||
| Current year | -21.17% |
| 1 week | 35.73 |  | 36.63 |
| 1 month | 35.11 | | 37.7 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 55 | 2017-10-09 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | -1.29% | -21.67% | +1.64% | 3.57B | |
| +0.49% | +2.04% | -13.96% | -6.39% | 13.56B | |
| +1.17% | -1.39% | -31.21% | -56.47% | 4.93B | |
| +2.06% | -1.16% | -1.26% | -3.48% | 4.62B | |
| +0.95% | -1.92% | -3.17% | -30.82% | 3.95B | |
| +0.82% | +2.75% | +0.08% | -0.77% | 3.53B | |
| +0.34% | -1.07% | -10.18% | +5.44% | 3.28B | |
| 0.00% | -2.11% | -22.33% | -16.15% | 2.33B | |
| -0.20% | -2.69% | -27.64% | -16.84% | 1.68B | |
| -0.45% | -2.44% | -2.01% | -15.09% | 1.66B | |
| Average | +0.51% | +0.07% | -13.34% | -13.89% | 4.31B | |
| Weighted average by Cap. | +0.66% | +0.54% | -13.31% | -13.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 734M 632M 595M 543M 1.02B 69.35B 1.02B 7.03B 2.73B 35.58B 2.76B 2.7B 115B | 5.35B 797M 686M 645M 589M 1.1B 75.25B 1.11B 7.63B 2.96B 38.61B 2.99B 2.93B 124B |
| Net income | 1.04B 154M 133M 125M 114M 213M 14.57B 214M 1.48B 573M 7.48B 579M 567M 24.08B | 1.18B 176M 152M 143M 130M 244M 16.65B 245M 1.69B 655M 8.54B 662M 648M 27.52B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CN¥35.96 | -0.06% | 1,933,014 |
| 26-09-03 | CN¥35.98 | +0.33% | 1,464,626 |
| 26-09-02 | CN¥35.86 | -0.72% | 1,679,788 |
| 26-09-01 | CN¥36.12 | +0.22% | 1,905,714 |
| 26-08-31 | CN¥36.04 | -1.07% | 2,449,756 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.96
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
